Introduction: Blood glucose control is critical to slowing the onset of T2DM complications for individuals. National guidelines encourage clinicians and payers to ensure patient HbA1c lab results are less than 8.0%. Understanding the longitudinal patterns of HbA1c control among individuals with lab results over 8.0% is therefore an important undertaking. This study aims to characterize the proportion of individuals returning to HbA1c control within a one year period after an uncontrolled result.

Population and Study Design: Medicare Advantage (MA) patients with a large, national health and wellness company residing in Florida with a diagnosis of type 2 diabetes were included if they had an HbA1c lab value greater than or equal to 8.0% in 2016. Patients had at least one year of continuous coverage prior to the uncontrolled result and were followed until disenrollment, death, or a controlled HbA1c lab value, up to a maximum of one year. Cox regression stratified by initial HbA1c value (8.0-8.9%, 9.0-9.9%, 10.0-10.9%, 11.0-11.9%, 12.0%+) was used to assess the adjusted proportion of persons returning to control over the one year follow-up period. Confounders in the model included: demographic factors, supply of insulin, and comorbidities.

Results: The study cohort consisted of 28,026 persons who met the inclusion criteria (50.7% female, 57.4% white, mean age 71.9 years). Overall, 50.5% (95% CI: 50.0%, 51.1%) of persons achieved HbA1c control within the 1 year follow-up. Inability to return to control was driven by higher initial Hba1c [8.0-8.9% return rate: 61.6% (60.9%, 62.4%) vs. 9.0-9.9%: 39.4% (38.1%, 40.7%) vs. 12.0+%: 27.7% (25.1%, 30.2%)].

Implications: MA patients with HbA1c results greater than 9.0% experienced challenges resuming controlled status suggesting increased attention to this population may be warranted.


T.A. Cordier: Employee; Self; Humana Inc.. Stock/Shareholder; Self; Humana Inc.. V. Chiguluri: None. H. Hines: None. S.H. Clark: None. G. Haugh: None. R. Gumpina: None. V. Gopal: None. T.G. Prewitt: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at